Market Research Report
China Neurovascular Devices / Interventional Neurology Market Forecast 2021-2028
|Published by||Inkwood Research||Product code||1018654|
|Published||Content info||134 Pages
Delivery time: 2-3 business days
|China Neurovascular Devices / Interventional Neurology Market Forecast 2021-2028|
|Published: July 19, 2021||Content info: 134 Pages||
The China neurovascular devices / interventional neurology market is estimated to record a CAGR of 5.22% during the forecast period, 2021-2026. The surging elderly population and the increasing R&D activities in neuro therapies are the key factors driving the market growth.
The increasing aging population contributes to the prevalence of dementia in the rural and semi-urban provinces of the country. As per the World Bank data, the country is the largest globally with regard to population, influencing Alzheimer's prevalence.
Further, the country faces the greatest challenge of stroke. Approximately 2 million cases are registered every year. The growing incidences of stroke have led to increased awareness. The government is involved in spreading the knowledge and providing enhanced treatment, healthcare coverage, and medical technology. Moreover, China is investing more in the prevention and treatment of non-communicable diseases. Furthermore, the government has standardized the advanced techniques for stroke prevention and treatment for physicians across the country. Such factors are set to propel market growth in China.
Some of the leading companies in the market include: Kaneka Corporation, Microport Scientific Corporation, Terumo Medical Corporation (Microvention Inc), B Braun Melsungen AG, Medtronic Inc, etc.